Docoh
Loading...

AIMD Ainos

Amarillo Biosciences, Inc. (ABI) is a diversified healthcare company engaged in the discovery and development of pharmaceutical and biotech products. Our goal is to introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. We engage in the advancement of low-dose non-injectable interferon as a therapeutic treatment for numerous indications such as thrombocytopenia, Sjögren’s syndrome, hepatitis C virus (HCV) and influenza. ABI primarily operates through three divisions: Pharmaceutical, Medical and Consumer. The Pharmaceutical division leverages a proprietary library of over a hundred scientific and clinical data studies on various human and animal applications of low-dose interferon, for patent licensing and commercialization opportunities with global partners. The Medical division is focused on developing an innovative, state-of-the-art technology to treat metabolism related diseases such as Type 1 and Type 2 diabetes in Asia. The Consumer division includes a range of nutraceutical and food supplement products that utilize our unique liposomal delivery systems. ABI currently has offices in the United States and Taiwan.

Company profile

Ticker
AIMD, AMAR
Exchange
Employees
Incorporated
Location
Fiscal year end
Former names
AMARILLO BIOSCIENCES INC
SEC CIK
IRS number
751974352

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 May 21
24 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Ainos earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 9.38K 9.38K 9.38K 9.38K 9.38K 9.38K
Cash burn (monthly) 4.29K 23.35K 174.04K 132.22K 39.83K 41.94K
Cash used (since last report) 11.96K 65.09K 485.17K 368.61K 111.03K 116.93K
Cash remaining -2.58K -55.71K -475.8K -359.23K -101.65K -107.55K
Runway (months of cash) -0.6 -2.4 -2.7 -2.7 -2.6 -2.6

Beta Read what these cash burn values mean

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: abroad, academic, acquire, advantage, advertising, Advisor, alternative, Alternatively, amended, Amendment, Antigen, antitrust, appointed, approximately, arrangement, artificial, assist, attached, background, bacterial, BBA, begin, beneficial, Bernard, biotechnology, bookkeeping, Calculation, candidate, capacity, carefully, Cayman, CFR, characterized, chemically, choose, Chrystal, civil, classified, cleared, climate, Cohen, collection, collectively, commence, Companuy, compete, compliance, comply, compound, connection, consummated, consummation, contemplated, content, contract, convey, COO, copy, corrupt, Cosmetic, costly, Counsel, criminal, cultural, currency, custom, damage, degree, description, diagnostic, difficult, difficulty, digital, diminish, director, disruption, distance, diversion, duly, duration, embedded, employment, enacted, enforcement, entirety, environment, equivalence, Esq, ethical, evolving, exceed, exempt, EXH, exhibit, expansion, experienced, export, expose, exposed, fabrication, facility, Failure, feasible, fewer, foregoing, formal, Formation, formatting, gain, Geographic, geopolitical, greatly, growth, handling, helicobacter, hereto, Hung, HYPERLINK, iii, impairment, impede, improve, improved, Incentive, IND, index, individually, infection, infrastructure, injury, inspection, instance, intelligence, intense, Interactive, invention, investigational, John, judgment, judiciously, Junyong, kit, Label, labeling, labor, laboratory, Lan, language, Lawrence, Lee, legislative, likelihood, Lin, Linkbase, liquidity, Living, loan, local, location, long, Maggie, mailing, media, monetary, MPA, Mutual, nationalization, NDA, negative, negatively, newer, November, omitted, Option, orphan, ownership, Page, partially, path, pending, person, physical, PMA, pneumonia, POCT, political, precedent, preclinical, predecessor, predicate, premarket, prior, privacy, prohibiting, proposed, protection, pursuing, pylori, quickly, rapid, rare, recapitalization, recoup, reference, Registrant, registration, regularly, Release, rely, repatriation, reputation, rescinded, resident, resignation, resigned, resource, Restated, rigidity, risky, routine, satisfy, satisfying, scaling, Schema, scope, Secretary, selected, Settlement, Shelton, shorten, shorter, Similarly, situation, SMART, specific, specifically, Specimen, staffing, steadily, stockholder, storage, strain, strategic, Submission, subscription, succeed, successfully, superiority, support, synthesized, Taxonomy, term, terminated, terrorism, text, therapeutic, thereunto, threatened, timeframe, traditional, transaction, Trust, Trustee, Tsai, unanticipated, undergo, undersigned, Underwriter, Unfavorable, University, unpredictable, unreasonable, vaginal, vary, varying, Vice, Virginia, VOC, volatile, volume, Wang, war, West, wide, workforce, written, XBRL
Removed: ABI, accurate, administering, annual, anticipate, assessed, audit, avoidance, broad, budget, cardiovascular, carried, catastrophic, cGMP, challenging, cited, climbing, commensurate, comparability, conducting, controlling, COSO, criteria, dedicated, deficiency, delayed, demonstrating, detailed, detected, detrimental, Diabetic, diet, dietary, differential, discreet, dosage, East, emerge, employing, enrolling, ensuring, epidemic, estimate, estimated, eventual, exhausted, exhaustive, existence, explain, external, eye, factor, fairly, faster, finally, fiscal, forecast, function, GAAP, gateway, genetic, glucose, greenfield, healing, heart, hiring, history, hypoglycemic, identified, imply, incidence, inflation, intestinal, involve, issue, kidney, knowledge, leading, lessening, lifestyle, lifetime, liver, Maxisal, microvascular, million, minimize, misstatement, necessitate, nephropathy, nerve, neuropathy, obese, obesity, optimized, outpacing, Overview, overweight, packaging, pain, patient, people, pervasive, phase, poor, population, prediction, preparation, prevalence, prevalent, prevented, progressive, projected, promise, promulgation, proper, publication, Quarterly, receiving, recruitment, reduction, Reform, reliability, reliance, remain, response, rest, retaining, retinopathy, salary, satisfactory, secondary, segregation, short, show, size, small, stage, standardized, suffer, suffering, sufficient, sufficiently, susceptible, Taiwanese, timing, topping, training, transplant, treated, trend, trial, trillion, turn, undesirable, undue, upward, wasted, weaker, week, Western, worsening, wound